BeOne Medicines (ONC)

Profile

Full Name

BeOne Medicines Ltd.

Ticker Symbol

ONC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

February 2, 2016

Indexes

Not included

Website

http://beonemedicines.com

Employees

11000

Key Details

Price

$252.78(-0.52%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.81B(+54.96% YoY)

Annual EPS

-$6.11(+27.69% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $252.78
    ONC price is $252.78

    30-Day Relative Volume

    0.65
    ONC 30-day relative volume is 0.65

    Price Performance

    Price Most recent change

    -0.52%
    ONC price was down -0.52% on Jun 18, 2025

    Price YTD change

    +36.85%
    ONC price is up +36.85% since January 1st

    Price 1-year change

    +62.52%
    ONC price is up +62.52% year-on-year

    Price 3-year change

    +91.3%
    ONC price is up +91.3% over the past 3 years

    Price Range

    Price All-time high

    $426.56
    ONC price is currently -40.74% below its historical high of $426.56

    Price 3-year low

    $124.46
    ONC price is currently +103.10% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $27.36B
    ONC market capitalization is $27.36 billion

    Market cap 3-year change

    +84.63%
    ONC market capitalization is up +84.63% over the past 3 years

    Market cap All-time high

    $37.51B
    ONC market capitalization is currently -27.07% below its historical high of $37.51 billion

    Market cap sector rank

    96.16%
    ONC market capitalization is higher than 96.16% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.72%
    ONC shares outstanding is up +2.72% year-on-year

    Shares Outstanding 3-Year Change

    -3.49%
    ONC shares outstanding is down -3.49% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.44
    ONC beta is 0.44

    200-day SMA

    $223.73
    ONC price is currently +12.99% above its 200-day simple moving average

    50-day SMA

    $243.19
    ONC price is currently +3.94% above its 50-day simple moving average

    RSI

    50.32
    ONC 14-day relative strength index is 50.32

    Volume

    0.65
    ONC 30-day relative volume is 0.65

    ATR

    $8.00
    ONC average true range is $8.00

    10-day Historical Volatility

    42.45%
    ONC 10-day historical volatility is 42.45%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.81B
    ONC annual revenue is $3.81 billion

    Revenue Analysts estimate

    $5.10B
    ONC annual revenue is currently -25.31% lower than the consensus analysts' forecast

    Revenue 1-year change

    +54.96%
    ONC annual revenue is up +54.96% year-on-year

    Revenue Sector rank

    89.95%
    ONC annual revenue is higher than 89.95% of companies in Healthcare sector

    EPS

    EPS

    -$6.11
    ONC annual earnings per share is -$6.11

    EPS Analysts estimate

    $1.39
    ONC annual earnings per share is currently -539.25% lower than the consensus analysts' forecast

    EPS 1-year change

    +27.69%
    ONC annual earnings per share is up +27.69% year-on-year

    EPS Sector rank

    17.27%
    ONC annual earnings per share is higher than 17.27% of companies in Healthcare sector

    Profit

    Gross profit

    $3.22B
    ONC annual gross profit is $3.22 billion

    Gross margin

    84.41%
    ONC annual gross profit margin is 84.41%

    Operating profit

    -$568.20M
    ONC annual operating income is -$568.20 million

    Operating margin

    -14.91%
    ONC annual operating profit margin is -14.91%

    Net income

    -$644.79M
    ONC annual net profit is -$644.79 million

    Net margin

    -16.92%
    ONC annual net profit margin is -16.92%

    Expenses

    Total expenses

    $4.38B
    ONC annual total expenses is $4.38 billion

    Operating expenses

    $3.78B
    ONC annual total operating expenses is $3.78 billion

    Cost of goods sold

    $594.09M
    ONC annual cost of goods sold is $594.09 million

    Selling, general & administrative expenses

    $1.83B
    ONC annual SGA is $1.83 billion

    Depreciation and amortization

    $171.76M
    ONC annual depreciation & amortization is $171.76 million

    Interest expense

    -
    ONC annual interest expense value is unknown

    Income tax

    $111.78M
    ONC annual income tax is $111.78 million

    EBIT & EBITDA

    EBIT

    -$568.20M
    ONC annual earnings before interest & taxes is -$568.20 million

    EBITDA

    -$396.44M
    ONC annual EBITDA is -$396.44 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.92B
    ONC annual total assets is $5.92 billion

    Non current assets

    $1.93B
    ONC annual long term assets is $1.93 billion

    Current assets

    $3.99B
    ONC annual total current assets is $3.99 billion

    Cash and cash equivalents

    $2.63B
    ONC annual cash & cash equivalents is $2.63 billion

    Accounts receivable

    $676.28M
    ONC annual accounts receivable is $676.28 million

    Inventory

    $494.99M
    ONC annual inventory is $494.99 million

    Liabilities

    Total liabilities

    $2.59B
    ONC annual total liabilities is $2.59 billion

    Long term liabilities

    $373.79M
    ONC annual total long term liabilities is $373.79 million

    Current liabilities

    $2.21B
    ONC annual total current liabilities is $2.21 billion

    Accounts payable

    $405.00M
    ONC annual accounts payable is $405.00 million

    Debt

    Total debt

    $1.08B
    ONC annual total debt is $1.08 billion

    Total debt 1-year change

    +16.09%
    ONC annual total debt is up +16.09% year-on-year

    Long term debt

    $210.76M
    ONC annual long term debt is $210.76 million

    Short term debt

    $869.11M
    ONC annual short term debt is $869.11 million

    Equity & Capital

    Shareholders equity

    $3.33B
    ONC annual stockholders equity is $3.33 billion

    Book value

    $3.33B
    ONC annual book value is $3.33 billion

    Retained earnings

    -$8.61B
    ONC annual retained earnings is -$8.61 billion

    Working capital

    $1.78B
    ONC annual working capital is $1.78 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$140.63M
    ONC annual cash flow from operations is -$140.63 million

    Cash from operations 1-year change

    +87.85%
    ONC annual cash flow from operations is up +87.85% year-on-year

    Cash from investing

    -$548.35M
    ONC annual cash flow from investing activities is -$548.35 million

    Cash from investing 1-year change

    -1013.86%
    ONC annual cash flow from investing activities is down -1013.86% year-on-year

    Cash from financing

    $193.45M
    ONC annual cash flow from financing activities is $193.45 million

    Cash from financing 1-year change

    -53.55%
    ONC annual cash flow from financing activities is down -53.55% year-on-year

    CAPEX

    CAPEX

    $529.14M
    ONC annual capital expenditures is $529.14 million

    CAPEX 1-year change

    -11.26%
    ONC annual capital expenditures is down -11.26% year-on-year

    Free Cash Flow

    Free cash flow

    -$669.77M
    ONC annual free cash flow is -$669.77 million

    Free cash flow 1-year change

    +61.81%
    ONC annual free cash flow is up +61.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    84.41%
    ONC annual gross profit margin is 84.41%

    Operating margin

    -14.91%
    ONC annual operating profit margin is -14.91%

    Net margin

    -16.92%
    ONC annual net profit margin is -16.92%

    ROA & ROE

    ROA

    -11.00%
    ONC annual return on assets is -11.00%

    ROE

    -18.77%
    ONC annual return on equity is -18.77%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ONC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ONC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.82
    ONC price to book ratio is 7.82

    PB ratio Sector rank

    87.32%
    ONC price to book ratio is higher than 87.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.55
    ONC price to sales ratio is 6.55

    PS ratio Sector rank

    69.66%
    ONC price to sales ratio is higher than 69.66% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $25.84B
    ONC enterprise value is $25.84 billion

    Enterprise value Sector rank

    95.63%
    ONC enterprise value is higher than 95.63% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -221.82
    ONC EV/EBITDA is -221.82

    EV/EBITDA Sector rank

    0.61%
    ONC EV/EBITDA is higher than 0.61% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.80
    ONC annual current ratio is 1.80

    Quick ratio

    1.58
    ONC annual quick ratio is 1.58

    Leverage

    Debt to equity

    0.31
    ONC annual debt to equity ratio is 0.31

    Interest coverage ratio

    -
    ONC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    ONC piotroski f-score is 5

    Altman Z-Score

    4.99
    ONC altman z-score is 4.99

    Analyst ratings

    Recent major analysts updates

    May 8, 25 RBC Capital
    Outperform
    May 8, 25 Guggenheim
    Buy
    Apr 28, 25 RBC Capital
    Outperform
    Apr 24, 25 TD Securities
    Buy
    Apr 21, 25 JP Morgan
    Overweight
    Apr 16, 25 Guggenheim
    Buy
    Apr 10, 25 Guggenheim
    Buy
    Apr 7, 25 RBC Capital
    Outperform
    Feb 28, 25 Macquarie
    Outperform
    Feb 28, 25 Citizens Capital Markets
    Market Outperform

    Institutional Ownership

    Screeners with ONC included

    Growing Shares Outstanding
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for BeOne Medicines?
    • Does BeOne Medicines pay dividends?
    • What sector is BeOne Medicines in?
    • What industry is BeOne Medicines in?
    • What country is BeOne Medicines based in?
    • When did BeOne Medicines go public?
    • Is BeOne Medicines in the S&P 500?
    • Is BeOne Medicines in the NASDAQ 100?
    • Is BeOne Medicines in the Dow Jones?
    • When was BeOne Medicines's last earnings report?
    • When does BeOne Medicines report earnings?
    • Should I buy BeOne Medicines stock now?

    What is the ticker symbol for BeOne Medicines?

    The ticker symbol for BeOne Medicines is NASDAQ:ONC

    Does BeOne Medicines pay dividends?

    No, BeOne Medicines does not pay dividends

    What sector is BeOne Medicines in?

    BeOne Medicines is in the Healthcare sector

    What industry is BeOne Medicines in?

    BeOne Medicines is in the Biotechnology industry

    What country is BeOne Medicines based in?

    BeOne Medicines is headquartered in Switzerland

    When did BeOne Medicines go public?

    BeOne Medicines's initial public offering (IPO) was on February 2, 2016

    Is BeOne Medicines in the S&P 500?

    No, BeOne Medicines is not included in the S&P 500 index

    Is BeOne Medicines in the NASDAQ 100?

    No, BeOne Medicines is not included in the NASDAQ 100 index

    Is BeOne Medicines in the Dow Jones?

    No, BeOne Medicines is not included in the Dow Jones index

    When was BeOne Medicines's last earnings report?

    BeOne Medicines's most recent earnings report was on May 7, 2025

    When does BeOne Medicines report earnings?

    The next expected earnings date for BeOne Medicines is Aug 7, 2025

    Should I buy BeOne Medicines stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page